WITH AN EYE ON PATIENTS

Serial Number 97272238
Registration 7186053
700

Registration Progress

Application Filed
Feb 17, 2022
Under Examination
Approved for Publication
Jul 25, 2023
Published for Opposition
Jul 25, 2023
Registered
Oct 10, 2023

Trademark Image

WITH AN EYE ON PATIENTS

Basic Information

Serial Number
97272238
Registration Number
7186053
Filing Date
February 17, 2022
Registration Date
October 10, 2023
Published for Opposition
July 25, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 10, 2023
Registration
Registered
Classes
005

Rights Holder

EyePoint Pharmaceuticals US, Inc.

03
Address
Suite A 210
480 Pleasant Street
Watertown, MA 02472

Ownership History

EyePoint Pharmaceuticals US, Inc.

Original Applicant
03
Watertown, MA

EyePoint Pharmaceuticals US, Inc.

Owner at Publication
03
Watertown, MA

EyePoint Pharmaceuticals US, Inc.

Original Registrant
03
Watertown, MA

Legal Representation

Attorney
Kimberly Jarman

USPTO Deadlines

Next Deadline
1367 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231010)
Due Date
October 10, 2029
Grace Period Ends
April 10, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

16 events
Date Code Type Description Documents
Oct 10, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 10, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 25, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 25, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 5, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 16, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 16, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 16, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 16, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 16, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 2, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 2, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 2, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 23, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 21, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease
First Use Anywhere: Jan 12, 2022
First Use in Commerce: Jan 12, 2022

Classification

International Classes
005